University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Howard Maibach, M.D.


Dr. Howard Maibach is an expert in contact and occupational dermatitis and sees patient at the Environmental Dermatosis Clinic, which is part of the Dermatology Clinic. His specialty is dermatotoxicology, or skin exposure toxicity; allergies and skin disorders; and dermatopharmacology or the study of medications for skin disorders.

Maibach has been on the editorial board of more than 30 scientific journals and is a member of 19 professional societies including the American Academy of Dermatology, San Francisco Dermatological Society and the Internal Commission on Occupation Health. He is a professor in the Department of Dermatology at UCSF.

To make an appointment with Maibach, patients need a referral from a primary care doctor or dermatologist.


Dermatology Clinic
1701 Divisadero St., Third and Fourth Floors
San Francisco, CA 94115
Phone: (415) 353–7800
Fax: (415) 353–7870

Hours: Monday to Friday, 8 a.m. – 5 p.m.

More about Howard Maibach


Tulane University School of Medicine 1955


University of Pennsylvania Hospital, Dermatology 1961

Selected Research and Publications

  1. Isaksson M, Ale I, Andersen K, Diepgen T, Elsner P, Goossens A, Goh CL, Jerajani H, Maibach H, Matsunaga K, McFadden J, Nixon R, Sasseville D, Bruze M. Multicenter Patch Testing With a Resol Resin Based on Phenol and Formaldehyde Within the International Contact Dermatitis Research Group. Dermatitis. 2015 Sep-Oct; 26(5):230-4.
  2. Hamann D, Thyssen JP, Hamann CR, Hamann C, Menné T, Johansen JD, Spiewak R, Maibach H, Lundgren L, Lidén C. Jewellery: alloy composition and release of nickel, cobalt and lead assessed with the EU synthetic sweat method. Contact Dermatitis. 2015 Oct; 73(4):231-8.
  3. Isaksson M, Ale I, Andersen KE, Diepgen T, Goh CL, Goossens R A, Jerajani H, Maibach HI, Sasseville D, Bruze M. Patch Testing To a Textile Dye Mix by the International Contact Dermatitis Research Group. Dermatitis. 2015 Jul-Aug; 26(4):170-6.
  4. Kushwaha A, Murthy RN, Murthy SN, Elkeeb R, Hui X, Maibach HI. Emerging therapies for the treatment of ungual onychomycosis. Drug Dev Ind Pharm. 2015 Oct; 41(10):1575-81.
  5. Saxena S, Andersen RM, Maibach HI. Pitfalls in clinical trials reveal need for well tolerated, more effective depigmenting agents. J Dermatolog Treat. 2015 Oct; 26(5):440-50.
  6. Warshaw EM, Maibach HI, Taylor JS, Sasseville D, DeKoven JG, Zirwas MJ, Fransway AF, Mathias CG, Zug KA, DeLeo VA, Fowler JF, Marks JG, Pratt MD, Storrs FJ, Belsito DV. North american contact dermatitis group patch test results: 2011-2012. Dermatitis. 2015 Jan-Feb; 26(1):49-59.
  7. Roussel L, Gilbert E, Salmon D, Serre C, Gabard B, Haftek M, Maibach HI, Pirot F. Measurement, analysis and prediction of topical UV filter bioavailability. Int J Pharm. 2015 Jan 30; 478(2):804-10.
  8. Elkeeb R, Hui X, Murthy N, Maibach HI. Emerging topical onychomycosis therapies - quo vadis? Expert Opin Emerg Drugs. 2014 Dec; 19(4):489-95.
  9. Zheng Y, Chen H, Lai W, Xu Q, Liu C, Wu L, Maibach HI. Cathepsin d repairing role in photodamaged skin barrier. Skin Pharmacol Physiol. 2015; 28(2):97-102.
  10. Zug KA, Pham AK, Belsito DV, DeKoven JG, DeLeo VA, Fowler JF, Fransway AF, Maibach HI, Marks JG, Mathias CG, Pratt MD, Sasseville D, Storrs FJ, Taylor JS, Warshaw EM, Zirwas MJ. Patch testing in children from 2005 to 2012: results from the north american contact dermatitis group. Dermatitis. 2014 Nov-Dec; 25(6):345-55.
  11. Jung EC, Maibach HI. Animal models for percutaneous absorption. J Appl Toxicol. 2015 Jan; 35(1):1-10.
  12. Liu X, Kruger P, Maibach H, Colditz PB, Roberts MS. Using skin for drug delivery and diagnosis in the critically ill. Adv Drug Deliv Rev. 2014 Nov 20; 77:40-9.
  13. Nafisi S, Schäfer-Korting M, Maibach HI. Perspectives on percutaneous penetration: Silica nanoparticles. Nanotoxicology. 2015 Aug; 9:643-57.
  14. Vieille-Petit A, Blickenstaff N, Coman G, Maibach H. Metrics and clinical relevance of percutaneous penetration and lateral spreading. Skin Pharmacol Physiol. 2015; 28(2):57-64.
  15. Warshaw EM, Kingsley-Loso JL, DeKoven JG, Belsito DV, Zug KA, Zirwas MJ, Maibach HI, Taylor JS, Sasseville D, Fowler JF, Mathias CG, DeLeo VA, Pratt MD, Marks JG, Fransway AF. Body piercing and metal allergic contact sensitivity: North American contact dermatitis group data from 2007 to 2010. Dermatitis. 2014 Sep-Oct; 25(5):255-64.
  16. Chow M, Botto N, Maibach H. Allergic contact dermatitis caused by palladium-containing dental implants. Dermatitis. 2014 Sep-Oct; 25(5):273-4.
  17. Xu Q, Hou W, Zheng Y, Liu C, Gong Z, Lu C, Lai W, Maibach HI. Ultraviolet A-induced cathepsin K expression is mediated via MAPK/AP-1 pathway in human dermal fibroblasts. PLoS One. 2014; 9(7):e102732.
  18. Gorouhi F, Maibach H. Evidence or experience: that is the question. Am J Clin Dermatol. 2014 Jul; 15(3):147-8.
  19. Edwards A, Blickenstaff N, Coman G, Maibach H. Dermatotoxicologic clinical solutions: clinical management of fragrance mix #1 #2 patients? Cutan Ocul Toxicol. 2015 Jun; 34(2):167-70.
  20. Noury B, Coman G, Blickenstaff N, Maibach H. In vitro skin decontamination model: comparison of salicylic acid and aminophylline. Cutan Ocul Toxicol. 2015 Jun; 34(2):124-31.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.